LINK
This study systematically evaluates greenhouse gas (GHG) emissions reporting practices of European airline groups, covering both mandatory and voluntary key performance indicators (KPIs) under evolving regulatory frameworks. By analysing annual and sustainability reports from 16 major airline groups, the research identifies significant progress in the reporting of core metrics, with Scope 1 CO2 totals reported by 94 % and emissions intensity by 88 %, reflecting growing regulatory alignment and stakeholder expectations. However, persistent gaps remain: Scope 2 and Scope 3 reporting appears in only 56 % and 50 % of cases, respectively, while non-CO2 emissions are disclosed by just 38 %, despite forthcoming European Union Emissions Trading System (EU ETS) monitoring requirements. Reporting on sustainable aviation fuels (SAF) life-cycle emissions is limited (19 %), and CO2 offsetting disclosures are rare (6 %), complicating verification of decarbonisation claims and readiness for ReFuelEU Aviation and Carbon Offsetting and Reduction Scheme for International Aviation (CORSIA). The proliferation of voluntary KPI disclosures further complicates comparability due to a lack of standardization and clear definitions. These challenges are compounded by risks of greenwashing, where airlines selectively report favourable data such as emissions intensity, and greenhushing, where substantive achievements are under-communicated. The study concludes that while regulatory frameworks such as the Corporate Sustainability Reporting Directive (CSRD), the EU ETS, CORSIA, and ReFuelEU are driving improvements, further harmonization and methodological clarity are required to ensure transparency, comparability, and genuine progress toward aviation's climate goals.
DOCUMENT
Fysiotherapie en/of manuele therapie spelen een belangrijke rol in de zorg voor mensen met lage rugpijn. Om de kwaliteit van deze zorg te verbeteren is een richtlijn ontwikkeld die vervolgens geïmplementeerd dient te worden. Technologische innovaties zoals serious games kunnen een rol spelen bij de implementatie van deze richtlijn. In een gerandomiseerde gecontroleerde studie is onderzocht in hoeverre een serious game de implementatie van een richtlijn lage rugpijn bevorderd. Achtenveertig fysiotherapeuten/manueel therapeuten zijn at random toegewezen aan een serious game groep of een groep die voorlichting kreeg over de richtlijn. Uitkomstmaten in deze studie zijn de mate van adherentie aan de richtlijn (vignettentoets), ervaren knelpunten van implementatie, de mening van de deelnemer over de wijze van implementeren, en de mate waarin de richtlijn is gelezen en wordt toegepast in de praktijk naar eigen inschatting van de deelnemer. Na zes weken follow-up is er geen significant effect gevonden van de serious game op de mate van adherentie aan de richtlijn (0,4 punten op 100 puntsschaal; 95% betrouwbaarheidsinterval -4,0 tot 4,8) ten opzichte van de voorlichtingsgroep. Ook voor de andere uitkomsten werden geen statistisch significante effecten gevonden. Het introduceren van een serious game had derhalve geen groter effect op de mate van adherentie aan de richtlijn lage rugpijn dan voorlichting.
LINK
MULTIFILE
Dit Tech-Info-blad is tot stand gekomen binnen het kader van het kennisoverdrachtproject "Fabricage van producten met geavanceerde productiemiddelen voor het omvormen en verbinden - FPGP". In dit kader zijn ook de volgende publicaties uitgegeven: TI.07.37 - "Laserlassen van complexe producten" en TI.07.38 - "Geautomatiseerd buigen". Uitgebreide informatie betreffende het laserlassen is tevens te vinden op de websites www.dunneplaat-online.nl en www.verbinden-online.nl, waarop tevens de volgende relevante Tech-Info-bladen vrij gedownload kunnen worden: TI.99.08 - "Laserlassen van beklede plaat", TI.00.11 - "Oppervlaktebehandelingen met de laser (cladden, legeren en dispergeren)", TI.00.12 - "Laser- en waterstraalsnijden van gelamineerde en beklede plaat", TI.07.34 - "Laserlassen vs. conventionele lastechnieken", TI.07.35 - "Omvormen", IOP 7.2 - "Lasertransformatieharden", alsmede de praktijkaanbeveling PA.02.13 - "Oppervlaktebewerkingen met hoogvermogen lasers".
DOCUMENT
Abstract Specialist oncology nurses (SONs) have the potential to play a major role in monitoring and reporting adverse drug reactions (ADRs); and reduce the level of underreporting by current healthcare professionals. The aim of this study was to investigate the long term clinical and educational efects of real-life pharmacovigilance education intervention for SONs on ADR reporting. This prospective cohort study, with a 2-year follow-up, was carried out in the three postgraduate schools in the Netherlands. In one of the schools, the prescribing qualifcation course was expanded to include a lecture on pharmacovigilance, an ADR reporting assignment, and group discussion of self-reported ADRs (intervention). The clinical value of the intervention was assessed by analyzing the quantity and quality of ADR-reports sent to the Netherlands Pharmacovigilance Center Lareb, up to 2 years after the course and by evaluating the competences regarding pharmacovigilance of SONs annually. Eighty-eight SONs (78% of all SONs with a prescribing qualifcation in the Netherlands) were included. During the study, 82 ADRs were reported by the intervention group and 0 by the control group. This made the intervention group 105 times more likely to report an ADR after the course than an average nurse in the Netherlands. This is the frst study to show a signifcant and relevant increase in the number of well-documented ADR reports after a single educational intervention. The real-life pharmacovigilance educational intervention also resulted in a long-term increase in pharmacovigilance competence. We recommend implementing real-life, context- and problem-based pharmacovigilance learning assignments in all healthcare curricula.
MULTIFILE
The Junior Adverse Drug Event Manager (J-ADEM) team is a multifaceted intervention focusing on real-life education for medical students that has been shown to assist healthcare professionals in managing and reporting suspected adverse drug reactions (ADRs) to the Netherlands Pharmacovigilance Centre Lareb. The aim of this study was to quantify and describe the ADRs reported by the J-ADEM team and to determine the clinical potential of this approach. The J-ADEM team consisted of medical students tasked with managing and reporting ADRs in hospitalized patients. All ADRs screened and reported by J-ADEM team were recorded anonymously, and categorized and analysed descriptively. From August 2018 through January 2020, 209 patients on two wards in an academic hospital were screened for ADR events. The J-ADEM team reported 101 ADRs. Although most ADRs (67%) were first identified by healthcare professionals and then reported by the J-ADEM team, the team also reported an additional 33 not previously identified serious ADRs. In 10% of all reported ADRs, the J-ADEM team helped optimize ADR treatment. The ADR reports were largely well-documented (78%), and ADRs were classified as type A (66%), had a moderate or severe severity (85%) and were predominantly avoidable reactions (69%). This study shows that medical students are able to screen patients for ADRs, can identify previously undetected ADRs and can help optimize ADR management. They significantly increased (by 300%) the number of ADR reports submitted, showing that the J-ADEM team can make a valuable clinical contribution to hospital care.
MULTIFILE
Abstract Managing adverse drug reactions (ADRs) is a challenge, especially because most healthcare professionals are insufficiently trained for this task. Since context-based clinical pharmacovigilance training has proven effective, we assessed the feasibility and effect of a creating a team of Junior-Adverse Drug Event Managers (J-ADEMs). The J-ADEM team consisted of medical students (1st–6th year) tasked with managing and reporting ADRs in hospitalized patients. Feasibility was evaluated using questionnaires. Student competence in reporting ADRs was evaluated using a case-control design and questionnaires before and after J-ADEM program participation. From Augustus 2018 to Augustus 2019, 41 students participated in a J-ADEM team and screened 136 patients and submitted 65 ADRs reports to the Netherlands Pharmacovigilance Center Lareb. Almost all patients (n = 61) found it important that “their” ADR was reported, and all (n = 62) patients felt they were taken seriously by the J-ADEM team. Although attending physicians agreed that the ADRs should have been reported, they did not do so themselves mainly because of a “lack of knowledge and attitudes” (50%) and “excuses made by healthcare professionals” (49%). J-ADEM team students were significantly more competent than control students in managing ADRs and correctly applying all steps for diagnosing ADRs (control group 38.5% vs. intervention group 83.3%, p < 0.001). The J-ADEM team is a feasible approach for detecting and managing ADRs in hospital. Patients were satisfied with the care provided, physicians were supported in their ADR reporting obligations, and students acquired relevant basic and clinical pharmacovigilance skills and knowledge, making it a win-win-win intervention.
MULTIFILE
Purpose: The aims of this study were to investigate how a variety of research methods is commonly employed to study technology and practitioner cognition. User-interface issues with infusion pumps were selected as a case because of its relevance to patient safety. Methods: Starting from a Cognitive Systems Engineering perspective, we developed an Impact Flow Diagram showing the relationship of computer technology, cognition, practitioner behavior, and system failure in the area of medical infusion devices. We subsequently conducted a systematic literature review on user-interface issues with infusion pumps, categorized the studies in terms of methods employed, and noted the usability problems found with particular methods. Next, we assigned usability problems and related methods to the levels in the Impact Flow Diagram. Results: Most study methods used to find user interface issues with infusion pumps focused on observable behavior rather than on how artifacts shape cognition and collaboration. A concerted and theorydriven application of these methods when testing infusion pumps is lacking in the literature. Detailed analysis of one case study provided an illustration of how to apply the Impact Flow Diagram, as well as how the scope of analysis may be broadened to include organizational and regulatory factors. Conclusion: Research methods to uncover use problems with technology may be used in many ways, with many different foci. We advocate the adoption of an Impact Flow Diagram perspective rather than merely focusing on usability issues in isolation. Truly advancing patient safety requires the systematic adoption of a systems perspective viewing people and technology as an ensemble, also in the design of medical device technology.
DOCUMENT
Samenvatting Doel Door de COVID-19-pandemie is een nieuwe groep revalidanten ontstaan waarbij voor een deel intensieve multidisciplinaire geriatrische revalidatie cruciaal lijkt te zijn. Gezien de nog beperkt beschikbare wetenschappelijke kennis en ervaring met het ziektebeeld, was er behoefte aan een praktijkgericht groeidocument en een continu cyclisch proces om praktijkkennis en nieuwe wetenschappelijke kennis direct te implementeren in de praktijk. Dit artikel beschrijft het proces van ontwikkeling, implementatie, evaluatie en doorontwikkeling daarvan in de praktijk, welke onder bijzondere omstandigheden heeft plaatsgevonden. Methode Het hele proces van de totstandkoming van het multidisciplinaire CO-FIT+ revalidatieprogramma bestond uit multipele iteraties van de PDCA-cyclus op zowel projectorganisatie-, projectuitvoerings- als implementatieniveau. Het behandeladvies post COVID-19-geriatrische revalidatie van Verenso is gebruikt als leidraad. Dit is aangevuld met de kennis en expertise van de GRZPLUS-professionals, ketenpartners, aanbevelingen vanuit de beroepsverenigingen en kennis uit wetenschappelijk onderzoek onder andere op het gebied van geriatrische (long-)revalidatie en post IC-revalidatie. Resultaten Een multidisciplinair geriatrisch revalidatieprogramma CO-FIT+ welke is geïmplementeerd in de praktijk. Dit heeft geresulteerd in een uniforme werkwijze en een continue verbetercyclus.
DOCUMENT